How to know if cervical biopsy is cancer

The cervix is ​​a critical part of the female body, and cervical biopsy refers to the use of colposcopy to determine whether the body has cancer. Under the display of the colposcopy, it can be observed whether there is cervical cancer in the female cervix. You also need to pay more attention to changes in your body and have regular physical examinations.

How to know if cervical biopsy is cancer

During a cervical cancer biopsy, the doctor can make a preliminary judgment on the condition of the cervix and whether there is cervical cancer based on his or her own experience or the examination and lesions under the colposcopy. In addition, if the tissue pathology examination after the biopsy is cancer, that is, cervical cancer, the accuracy rate is very high. In general, if there is contact bleeding from the cervix or vaginal discharge with an odor, you should go to the hospital in time for screening for cervical precancerous lesions. TCT and HPV are the initial screenings. If TCT or HPV is positive, or HPV16 or 18 is positive, a cervical biopsy is also recommended to understand the condition of the cervix in a timely manner and rule out precancerous lesions or cervical cancer.

When cervical lesions occur, a cervical biopsy is required to confirm whether the cervical tissue has become cancerous. Cervical biopsy is usually performed at the junction of the squamous and columnar parts of the external cervical os, or by clamping cervical tissue at an obvious lesion for pathological examination. In order to improve the accuracy of diagnosis, acetic acid and 3% iodine solution can be applied locally to the cervix, and then the image changes of local tissues can be observed under a colposcope. Samples can be taken from the positive area and then sent for pathological examination. The morphology of the cells and the tissue origin can be observed under a microscope to determine whether the cervical tissue has become cancerous.

Routine physical examinations use physical and biochemical methods, generally using imaging methods such as CT, color ultrasound, and MRI. In other words, the tumor will only be discovered when it has formed a mass and is relatively large in size. With the completion of the world's human genome project, we have entered the genetic age. Studies have found that the vast majority of human diseases are closely related to genes. Genetic testing can help to detect malignant tumors at an early stage. The C12 multi-tumor marker protein chip combined detection system is currently the most advanced technical means in the world for early screening of tumors.

Tumor markers refer to certain specific substances secreted by tumor cells during their occurrence and development. By capturing these specific substances through technical means, the presence of tumor cells can be predicted and determined. It can be detected in the early stages of the tumor, even before it forms a mass. Therefore, C12 multi-tumor marker combined with gene testing is fully capable of realizing early detection of malignant tumors! Its detection rate exceeds 80%!

C12 can detect 12 tumor markers and can detect the 10 most common malignant tumors at an early stage: esophageal cancer, gastric cancer, liver cancer, pancreatic cancer, colorectal cancer, breast cancer, ovarian cancer, cervical cancer, and prostate cancer.